MASS East - Medical Affairs Strategic Summit

Develop a unified scientific voice and ultimately help position your medical affairs group as a strategic, customer-facing function

Morristown, NJ, United States

Medical Affairs Executive Strategy

Medical affairs teams are involved in nearly all aspects of communication in a pharmaceutical/biotechnology/medical device organization. Their scope and authority can vary depending on the size of the business. One of the biggest issues medical affairs teams have faced in recent years has been the need to establish standard operating procedures and quality control measures for social media posts. With Twitter, Facebook and other networks in use by virtually all employees, medical affairs teams need to pinpoint who regulates company posts, what information is released and how posts should be edited.

This track will address the management and communication concerns internal teams face as well as how to best improve current processes in order to comply with new regulations and the instant access to information.

This conference is designed for representatives from pharmaceutical, biotechnology and medical device organizations with responsibilities in the following areas:
  • Medical Affairs/Field Medical Affairs
  • Medical Science/Field Medical Science
  • Clinical/Scientific Affairs
  • Medical Strategy/Communications
  • Key Opinion Leadership/Thought Leadership/Opinion Leader Relationships
  • Research and Development
  • Medical Education
  • Publication Planning
  • Scientific Communication
  • Program Management
  • Quality Assurance
  • Scientific Engagements
  • Medical Science Liaisons

MSL Best Practices

The role of the medical science liaison (MSL) has continued to expand. Previously, MSLs served as the link between their respective organizations and key opinion leaders (KOLs). As subject matter experts, MSLs convey product information to educate the KOL, then relay information back to their own organization. While this has not changed, MSLs are now taking on a more hybrid role, encompassing account/relationship management responsibilities in addition to interacting with clinical and business teams. To maintain the expanding list of responsibilities, MSLs need to be continuously trained and assessed for regulatory compliance and other various roles.

Accompanying the growth of the MSL role, data indicates that KOLs and physicians increasingly prefer to work with MSLs instead of sales or account managers.

The MSL Best Practices track will focus on the MSL's growing duties and on the exchange of MSL training and evaluation techniques in both small and large organizations.

This conference is designed for representatives from pharmaceutical, biotechnology and medical device organizations with responsibilities in the following areas:
  • Medical Science Liaisons
  • Medical Science
  • Medical Strategy
  • Scientific Communication
  • Medical Education
  • Key Opinion Leadership/Thought Leadership/Opinion Leader Relationships

Featuring Presentations, Panel Discussions and Case Studies, Including:

  • Drive alignment and improve dialogue across medical and commercial functions to create a unified brand strategy
  • Identify opportunities to partner with patient advocacy groups and leverage their insight to incorporate endpoints and outcomes important to key external stakeholders
  • Harmonize medical strategic planning across key geographies to enhance collaboration between U.S. and global medical affairs teams
  • Explore different avenues and technologies that can allow MSL teams to profile and segment customer channels to support customer engagement
  • Understand how the value discussion has evolved over time as a requirement by external stakeholders and learn the impact that both clinical and economic information can have for KOLs, payers, and healthcare systems
  • Explore different operating models for medical affairs groups and discuss how organizational structure can impact the effectiveness of your activities

Who Should Attend:

This conference is designed for representatives from pharmaceutical, biotechnology, and medical device organizations with responsibilities in the following areas:
  • Medical Affairs/Field Medical Affairs
  • Clinical/Scientific Affairs
  • Medical Science Liaisons/MSLs
  • Medical Strategy/Communications
  • Medical/Clinical Operations
  • KOL/Thought Leader Relations/Engagement
  • Investigator-Initiated Research (IIR)
  • Investigator-Initiated Studies (IIS)
  • Investigator-Initiated Trials (IIT)
  • Investigator-Sponsored Trials (IST)
  • Research Collaborations
  • Medical/Scientific/Patient Communications
  • Medical Information
  • Medical Education
  • Publication Planning
  • Health Economics and Outcomes Research/HEOR
  • Compliance/Legal
  • Regulatory Affairs
  • Research Grants
  • Call Center Management
  • Patient Services
  • Clinical Outcomes and Publications
This conference is also designed for:
  • KOL and Thought Leader Mapping Organizations
  • Data Management Vendors
  • Clinical Trial Service Providers
  • Scientific and Technology Solutions Providers
  • Medical Affairs Service Organizations
  • Medical and Scientific Communication Vendors
  • Talent Acquisition Service Providers
  • Call Center Vendors
  • Companion Diagnostics
  • Data Management Solution Providers
  • Clinical Outcomes and Publications


  • Kevin Appareti, Senior Director, Global Medical Science Liaison, PHILIPS HEALTHCARE
  • Jacqueline S. Armani, O.D., FAAO, Medical Science Liaison, ALCON
  • Terry Babb, Pharm.D., Senior Director and Head, Global Medical Strategy and Training, TAKEDA PHARMACEUTICALS
  • Michael Banks, M.D., Managing Director, BESTMSLS, President, - THE DOCTOR'S CHANNEL
  • Colville Brown, M.D., Executive Medical Director, INNOCOLL PHARMACEUTICALS
  • Ryan Case, Ph.D., Director, U.S. Medical Affairs, NEURODERM
  • Joseph Chiao, M.D., Medical Director, Therapeutic Area Head, CSL BEHRING
  • Stacy Martin Conner, Pharm.D., MBA, Field Director, Medical Science Liaisons - Women's Health, ABBVIE
  • Duke Dickerson, Ph.D., M.Sc., MBA, Regional Medical Director, Orphan and Rare Diseases, HORIZON PHARMA
  • Howard Dorfman, Distinguished Visiting Practitioner and Adjunct Professor, SETON HALL UNIVERSITY SCHOOL OF LAW
  • Matthew M. Goodwin, Pharm.D., MBA, Director, Medical Affairs, ARSANIS
  • Dan Hennessy, Ph.D., M.S., MBA, Vice President, Field Medical Affairs, EMD SERONO
  • Lance Hill, CEO, WITHIN3
  • David Jacobs, Assistant General Counsel, Commercial Brands, DAIICHI SANKYO
  • Mike Jozefowicz, Associate Director, Consultative Services, IQVIA TECHNOLOGIES
  • Randall E. Kaye, M.D., Chief Medical Officer, CLICK THERAPEUTICS
  • Teresa Kelton, J.D., Pharm.D., MPH, Senior Director, R&D Counsel, ALEXION PHARMACEUTICALS
  • Diya Lahiri, Executive Vice President, Global Business Lead, MEDISTRAVA
  • Matt Lewis, Global Chief Data and Analytics Officer, MEDISTRAVA
  • Rob Livada, Vice President, Solution Architecture, CYBERGRANTS
  • Bill Maltas, Medical Science Liaison, CIRCASSIA
  • Jing L. Marantz, M.D., Ph.D., Senior Vice President, Head of Medical Affairs, ALNYLAM
  • Pamela Morris, Director, Key Accounts, KOMODO HEALTH
  • Poushali Mukherjea, Ph.D., Executive Director, Medical Affairs, BRISTOL-MYERS SQUIBB
  • Marissa Nolan, Ph.D., CMPP, Vice President, Group Scientific Director, LOCKWOOD GROUP
  • Marty Perz, Immunotherapy Sales Specialist, DENDREON
  • Sandra Petralia, Ph.D., Principal Medical Science Liaison, CLOVIS ONCOLOGY
  • Terri L. Phillips, M.D., Vice President and Head of Global Medical Affairs, MERZ
  • Michael W. Ravotti, DHSc, PA-C, Senior Associate Director CDMA, Field-Based Medicine Respiratory MSLs, BOEHRINGER INGELHEIM
  • Howard Rutman, M.D., Vice President, Medical Affairs, DAIICHI SANKYO
  • Sagar Shah, Pharm.D., Senior Director and Head, Field Medical Affairs, AKCEA THERAPEUTICS
  • Archie Stone, Ph.D., Vice President, Medical Affairs, ALCRESTA THERAPEUTICS
  • Beate Stych, M.D., Vice President, Head, Medical Affairs, REGENERON PHARMACEUTICALS
  • Monica Arora Sukhatme, Pharm.D., Head of U.S. Medical Affairs, NANOBIOTIX
  • Davida J. White, M.D., Head, U.S. Medical Affairs, INDIVIOR
  • Javier Zambrano, M.D., Medical Director Gastroenterology, U.S. Medical Affairs, ABBVIE
  • Dan Zavodnick, Senior Associate General Counsel, KEDRION BIOPHARMA
Pre-Conference Workshops - Wednesday, April 24, 2019

Conference Day One - Thursday, April 25, 2019

Conference Day Two - Friday, April 26, 2019
Westin Governor Morris
2 Whippany Road
Morristown, NJ 07960

To make reservations over the phone, please call 973-539-7300 and request the negotiated rate for "ExL's MASS East 2019". To make reservations online, please CLICK HERE

You must book your room by April 9, 2019, in order to receive the group rate. Please book your room early, as rooms available at this rate are limited.